Cytomos

Cytomos develops a proprietary cell analysis platform for the biopharma industry.

Edinburgh, UK—Founded 1992

£5.6MTotal raised

Edinburgh-based life science business that has created a proprietary cell analysis platform called Cytomos Dielectric Spectroscopy.

Filed accounts

Cash at bank

Members only

Net current assets

Members only

Total assets less current liabilities

Members only

Net assets

Members only

Shareholders' funds

Members only

Fixed assets

Members only

Cash, assets and headcount from Cytomos's latest Companies House filing — with year-on-year movement, free with a Winfred account.

Create free account Sign in

Team

David Rigterink

CEO

David is the CEO of Cytomos, having previously held senior sales, marketing, and specialist roles across biopharma and life sciences companies including Sartorius and Pall Corporation.

Lindsay Fraser

CSO

Alan Raymond

Executive Chairman

Alan brings extensive board experience, having served as chairman and non-executive director across multiple life sciences and biotechnology companies including Cytomos, ImmuONE, and Diurnal Limited.